OSTEOPOROSIS

Adverse reaction reported in 25,350 FDA reports across 15 drugs.

25,350
Total Reports
15
Drugs Involved
Emtricitabine / Tenofovir Disoproxil Fumarate
Most Reported Drug

Drugs Associated with OSTEOPOROSIS

Drugs where "OSTEOPOROSIS" was reported as an adverse event.

# Drug Reports % of Total
1 Emtricitabine / Tenofovir Disoproxil Fumarate 7,264
28.7%
2 Tenofovir Disoproxil 5,384
21.2%
3 Bictegravir Sodium, Emtricitabine, / Tenofovir Alafenamide Fumarate 2,766
10.9%
4 Emtricitabine / Tenofovir Alafenamide 2,265
8.9%
5 Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Alafenamide 1,937
7.6%
6 Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Disoproxil Fumarate 1,737
6.9%
7 Ritonavir 863
3.4%
8 Medroxyprogesterone 483
1.9%
9 Darunavir 437
1.7%
10 Raltegravir 430
1.7%
11 Dolutegravir 425
1.7%
12 Lopinavir / Ritonavir 400
1.6%
13 Atazanavir 398
1.6%
14 Raloxifene 292
1.2%
15 Lamivudine / Zidovudine 269
1.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused osteoporosis. Always consult your healthcare provider.